Synchrony Symposia
Synchrony 2026 – Understanding Medical Conditions in Youth/Young Adults with ASD – took place on August 30 in Palo Alto, California. It was a whole day event that featured speakers from leading academic and clinical institutions.
Synchrony 2026 video recordings are now available for purchase.
What is Synchrony?
First and only international symposium on translational research and clinical advances in autism and related health comorbidities that brings together academia, physicians and members of the community with the goal to catalyze scientific research that can improve the quality of life for those with neurological disorders and developmental disabilities through safe and evidence-based medicine.
An interdisciplinary forum for the brightest minds to collaborate and innovate, and for parents, caregivers and families to learn about complex medical conditions in autism.
Together we are advancing research, improving clinical care, and bringing hope to individuals with autism and their families.
SYNCHRONY SPONSORS
Thank you to our wonderful sponsors!
platinum sponsor
We wish to express our gratitude to our generous sponsors, above all the fantastic CharmHealth for their continuous support and dedication to our cause. Powered by cutting-edge AI, CharmHealth offers a comprehensive suite for medical practices of all sizes. From practice management and an EHR to billing and revenue cycle management, CharmHealth provides everything a healthcare practitioner needs to run efficiently and focus on patient care.
gold sponsor
Thank you also to the O’Sullivan Foundation, whose mission is to support causes that help enable people to help themselves, through education, employment, research and disruptive advances of technology.
ORGANOIDS
GASTROENTEROLOGY
NEUROLOGY
TREATMENT TRIALS
BIOMARKERS
IMMUNOLOGY
GENETICS
ANIMAL MODELS
EPILEPSY & SEIZURES
NEUROINFLAMMATION
FDA APPROVAL
NOVEL THERAPEUTICS
BASIC SCIENCE
NEUROLOGY
ENDOCRINOLOGY
ORGANOIDS
GASTROENTEROLOGY
NEUROLOGY
TREATMENT TRIALS
BIOMARKERS
IMMUNOLOGY
GENETICS
ANIMAL MODELS
EPILEPSY & SEIZURES
NEUROINFLAMMATION
FDA APPROVAL
NOVEL THERAPEUTICS






